Get in Touch



SL-3716

Osimertinib impurity A, 98%

CAS No. : 
[1421373-98-9]    
Synonyms : N-(5-((4-(1H-Indol-3-yl)pyrimidin-2-yl)amino)-2-((2-(dimethylamino)ethyl)(methyl)amino)-4-methoxyphenyl)acrylamide; AZ-5104

Price and Availability
Pack Size Price in USD Quantity Availability Shipping Status
25MG150.00 Back Order Estimated to Ship on 01.20.2025
250MG1200.00 Back Order Estimated to Ship on 01.20.2025
Chemical Properties
C27H31N7O2 485.58
Off-white solid Not available
For Laboratory research use only, not for drug, household or other uses.
Applications : It is an impurity of Osimertinib (Osimertinib impurity A). A third-generation epidermal growth factor receptor (EGFR) inhibitor, used to treat non-small-cell lung carcinomas with a specific mutation.
References : Finlay M. R. et al. J. Med Chem., 57(20), 8249-8267, 2014; Cross D. A. et al.: Cancer Discov., 4(9), 1046-1061, 2014; Eberlein C. A. et al.: Cancer Res., 75(12), 2489-2500, 2015.
Storage : Keep container tightly closed under nitrogen or argon and refrigerate for long-term shelf life.
Caution : In case of contact with skin or eyes, rinse immediately with plenty of water and seek medical advice. Wear suitable protective clothing and gloves.

To receive price and delivery information on larger quantities, please complete the form below and we will respond promptly.

If you login prior to completion of the form, your contact information will automatically populate.

Your request for quote will also be accepted by e-mail at sales@syninnova.com or Fax: +1 780 485 2963.

Product ID : SL-3716

Product Name : Osimertinib impurity A

Note : If you do not find your required compound in our catalogue, or not commercially available, please contact us, we will assist you to get your desired molecule. We only charge if we deliver to your satisfaction.

Site is under construction and it will coming soon. Please contact us at sales@syninnova.com for COA. Thank you!

Site is under construction and it will coming soon. Please contact us at sales@syninnova.com for HNMR. Thank you!